YAP1 and cancer: Depletion or inhibition of YAP/TAZ through pharmacological agents, or re-expression of tumor suppressors in the Hippo pathway reverts the drug sensitivity, suggesting intervention of YAP/TAZ activity is a prospective strategy to overcome drug resistance in cancer cells.